Quick Facts
FONT-SIZE Plus   Neg
Share SHARE

MGT Capital ReportsAdministrative Change To Proposed Reverse/Forward Stock Split

MGT Capital Investments, Inc. (MGT: Quote) said that it was notified on March 15, 2012 by NYSE Amex LLC that the Company was expected to require that Company shareholders surrender their share certificates upon the effectiveness of the Company's previously disclosed reverse-forward stock split. The combined Reverse/Forward Split ratio equates to approximately 1-for-33 shares of Common Stock.

The company anticipates that the Reverse/Forward Split will become effective on March 21, 2012 following approval at a special meeting of the shareholders of the Company to be held on March 20, 2012.

Click here to receive FREE breaking news email alerts for MGT Capital Investments Inc. and others in your portfolio

by RTT Staff Writer

For comments and feedback: editorial@rttnews.com

Business News

Quick Facts

Editors Pick
Specialty drugmaker Horizon Pharma plc (HZNP) on Friday managed to redomicile itself as an entity incorporated in Ireland following the completion of its $660 million acquisition of Vidara Therapeutics International plc. The deal will help it avoid paying the high rate of U.S. corporate taxes. The... Stocks showed a lack of direction over the course of the trading day on Friday after failing to sustain an initial upward move. Despite the choppy trading, the Dow once again managed to end the session at a new record closing high. The major averages turned in a mixed performance on the day. President Barack Obama delivered a statement Thursday evening thanking members of Congress for voting to approve legislation granting the U.S. military the authority to train and arm moderate Syrian rebels fighting against the terrorist group known as the Islamic State.
comments powered by Disqus
FREE Newsletters, Analysis & Alerts

 

Stay informed with our FREE daily Newsletters and real-time breaking News Alerts. Sign up to receive the latest information on business news, health, technology, biotech, market analysis, currency trading and more.